2023 Colorado Revised Statutes › Title 23 - POSTSECONDARY EDUCATION (§§ 23-1-101 — 23-81-102) › STATE UNIVERSITIES AND COLLEGES (§§ 23-1-101 — 23-56-111) › STATE UNIVERSITIES AND COLLEGES (§§ 23-20-101 — 23-56-111) › Article 21 - UNIVERSITY OF COLORADO - UNIVERSITY HOSPITAL - CENTERS (§§ 23-21-101 — 23-21-1105) › Part 8 - MEDICATION-ASSISTED TREATMENT (MAT) › Section 23-21-807 - [Effective 8/7/2024] Reporting requirements

(1)
Each organization, practice, or pharmacy that receives a grant through the pilot program shall submit an annual report to the center by a date set by the center. At a minimum, the report must include the following information:
(a)
The amount of the grant and the date on which the grant was received;
(b)
An accounting of how the grant money was spent and whether any grant money was not expended;
(c)
The number of nurse practitioners, physician assistants, or pharmacists who were trained; and who received certification to prescribe buprenorphine and all other medications and therapies approved by the federal food and drug administration to treat opioid use disorder; and
(d)
A detailed description of the training received by nurse practitioners or physician assistants; whether the nurse practitioners or physician assistants completed the training and attained status as a qualified nurse practitioner or physician assistant; whether the nurse practitioners or physician assistants that attained qualified nurse practitioner or physician assistant status are currently able to provide and are providing medication-assisted treatment to opioid-dependent patients; the number of individuals with opioid use disorders treated in the previous two years before the pilot program; and the number of opioid-dependent patients treated during the pilot program period by each qualified nurse practitioner or physician assistant.
(e)
A detailed description of the training received by pharmacists; whether the pharmacists who received training are currently able to provide and are providing medication-assisted treatment to opioid-dependent patients; and the number of opioid-dependent patients treated during the pilot program period by each pharmacist.
(2)
The center shall annually submit a summarized report on the pilot program to the health and human services committee of the senate and the health and insurance and the public health care and human services committees of the house of representatives, or any successor committees, and to the governor. At a minimum, the report must include:
(a)
A description of the pilot program, including a list of counties participating in the pilot program;
(b)
A list identifying the grant recipients, including the amount awarded to each grant recipient, the county in which the grant recipient is providing services, and a detailed description of how each grant recipient used the grant award;
(c)
[Repealed by 2024 Amendment.]
(d)
The total number of patients served during the course of the pilot program, listed by county participating in the pilot program;
(e)
A summary of policies and procedures instituted by grant recipients related to the provision of MAT by qualified nurse practitioners, physician assistants, and pharmacists;
(f)
A summary of evaluation results of the pilot program; and
(g)
A summary of lessons learned and recommendations for implementing MAT as provided by nurse practitioners, physician assistants, and pharmacists in other communities in the state.
Amended by 2024 Ch. 470,§ 17, eff. 8/7/2024.
Amended by 2019 Ch. 173, § 6, eff. 5/14/2019.
Added by 2017 Ch. 226, § 1, eff. 5/22/2017.
L. 2017: Entire part added, (SB 17-074), ch. 226, p. 876, § 1, effective May 22.
2024 Ch. 470, was passed without a safety clause. See Colo. Const. art. V, § 1(3).
This section is set out more than once due to postponed, multiple, or conflicting amendments.